Mentor Capital Takes Investment Position in Each of 10 Cancer Immunotherapy Index Companies
1/19/2010 9:20:01 AM
SAN DIEGO--(BUSINESS WIRE)--Mentor Capital, Inc. (Pink Sheets:MNTR) has completed the set-up and initial funding of the Cancer Immunotherapy Index Fund. Through the CII Fund, Mentor Capital has now taken an initial equity position in each of the ten companies that make up Mentor Capital's proprietary Cancer Immunotherapy Index. The equally weighted CI Index was first created by Mentor Capital to track the growth of the cancer immunotherapy sector on an information basis. Since its formation in July 2009, the CI Index has appreciated at an approximate 100% annualized rate.
comments powered by